Skip to content
Gigantum.net

Search

Search covers the most recently published. For the full archive, browsethe topics.

40 results for"Dave the Diver"

Today’s Vergecast: The many pluses and minuses of Alexa Plus.

Amazon is determined to turn Alexa Plus into a do-everything AI assistant that can compete with Gemini, ChatGPT, Claude, and the rest. But after a year of testing, The Verge’s Jen Tuohy has mixed feelings on how it’s all going. And on whether a new tablet is the right way to fix it. Watch | Listen | Get ad-free [Media: https://youtu.be/AhHB6eLlQ_8]

Former OpenAI safety researchers ask for more transparency about their firings.

In a letter to OpenAI, Tomek Korbak, Jasmine Wang, and Mikita Balesni push back on OpenAI’s claims that they shared confidential information with an outside AI safety group. The three researchers say they “acted in line with OpenAI’s mission,” and raise concern that their firings could “justify ending OpenAI’s work with METR,” the AI safety organization that investigated the rogue Hugging Face hack. [Link: Mikita Balesni (@balesni) | https://x.com/balesni/status/2108262814003687745?s=20 | X (formerly Twitter)]

Xbox XP's First Task Should Be the Halo Movie We Never Got

Microsoft has just announced Xbox XP, a new division aimed at getting cool experiences – be they movies, TV shows, theme park attractions, etc. – made out of its many intellectual properties. And that's how Microsoft can erase the memory of the TV show you probably already forgot anyway. No, I'm not suggesting that they necessarily dust off Garland's 20-year-old script (unless it's awesome, then by all means, do it!), but by turning Halo into the movie we deserve but never got.

The Trump administration seems like its leaning toward allowing unapproved peptides.

So says The Washington Post. I’ve been writing about gray-market peptides in Optimizer, but this is a follow-up to July’s FDA hearings about whether compounding pharmacies should be allowed to sell unapproved peptides. It’s unclear which ones, and the timing could change, but the Post says this might give the administration a “political upside.” [Link: Trump administration paving way for temporary sale of some unapproved peptides | https://www.washingtonpost.com/health/2026/10/07/trump-administration-paving-way-temporary-sale-some-unapproved-peptides/ | The Washington Post]

Thursday, October 8, 2026

© 2026 Gigantum.net. Content gathered automatically from external sources; rights to each text belong to whoever originally published it.